Author:
Requejo C.,Ruiz-Ortega J. A.,Bengoetxea H.,Garcia-Blanco A.,Herrán E.,Aristieta A.,Igartua M.,Ugedo L.,Pedraz J. L.,Hernández R. M.,Lafuente J. V.
Publisher
Springer Science and Business Media LLC
Subject
Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology
Reference47 articles.
1. Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744–1754
2. Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson’s disease. Neurology 72:1–136
3. Gibb WR (1997) Functional neuropathology in Parkinson’s disease. Eur Neurol 38(Suppl 2):21–25
4. Herrán E, Requejo C, Ruiz-Ortega JA, Aristieta A, Igartua M, Bengoetxea H, Ugedo L, Pedraz JL, Lafuente JV, Hernández RM (2014) Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease. Int J Nanomedicine 9:2677–2687
5. Franco V, Turner RS (2012) Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs. Neurobiol Dis 47:114–1125
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献